Concert Pharmaceuticals CNCE
$ 8.37
0.0%
Quarterly report 2022-Q3
added 11-07-2022
Country |
USA |
IPO year |
2014 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Roger Tung |
Employees in the company |
70 |
Shares |
34.4 M |
Market Cap[1] |
$ 401 M |
EBITDA (LTM) |
$ -83.8 M |
P/E (LTM) |
-3.75 |
P/S (LTM) |
12.32 |
EPS (LTM) |
-2.23 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.